Despite widespread use in hypertensive children, the safety and effectiveness of lisinopril had not been previously tested in a controlled
Sinha, +2 authors
Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial
Maya Guglin
Background Most patients with hypertension require more than one antihypertensive to achieve blood pressure (BP) control
Objective: To compare the effects of an angiotensin-converting enzyme (ACE) inhibitor (ramipril), a
Lisinopril has some key features that make it different from enalapril and captopril; 1) it has a long half-life, 2) it is hydrophilic, and 3) it is not broken down by the liver
Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial
Although ACE inhibition was found to be clinically well tolerated in these studies, laboratory safety data were limited
Patients were recruited from 18 European centres, and were not on medication for hypertension
Patients with gestational hypertension, preeclampsia, and preeclampsia superimposed on chronic hypertension
Early lowering of blood pressure with lisinopril and labetalol after acute stroke seems to be a promising approach to reduce mortality and potential disability
Study design: This randomized controlled trial conducted between June 2014 and June 2015 included women who delivered at ≥32 weeks' gestation with persistent postpartum hypertension (sustained ACEIs, like lisinopril, are one of the first-line drugs used to treat high blood pressure
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)